Team finds likely culprit behind liver problems linked to intravenous feeding

Researchers know that feeding some patients intravenously can save their lives – but also can cause liver damage. Now scientists at the University of Colorado and Children's Hospital Colorado have figured out the likely culprit, one of the ingredients in intravenous food, behind the liver problems.

The discovery, published Oct. 9 in Science Translational Medicine, could point the way to better treatments for patients who are medically vulnerable and, often, very young.

"We still have more to learn about the optimal mix of lipids for intravenous nutrition," said Ron Sokol, part of the research team. "Our hope is that this study will lead us to intravenous nutrition that results in less stress on the ."

A life-saving option for some patients with intestinal problems or pancreatitis is to provide food intravenously. But this option, usually used for patients who can't tolerate or absorb food from their intestines, is associated with while helping in other ways.

The risk is especially high for premature infants and children with intestinal failure or short bowel syndrome, who often depend on intravenous feeding – or Parenteral nutrition (PN)—for years. The longer a patient is on PN and the more severe their intestinal problems, the greater the risk of what is called PN-associated liver disease (PNALD).

Clinical evidence had suggested that lipids derived from might be part of the problem. The researchers, also representing University of Cincinnati, Cincinnati Children's Hospital and Emory University, zeroed in on the soy factor.

They found that one derivative of soy – called stigmasterol – appeared to prevent the flow of bile from the liver in experimental mice. They also figured out the chemical mechanism behind that problem, and found that microbes in the gut appeared to contribute to PNALD as well.

"The results of this study may help promote a shift away from solutions containing stigmasterol for dependent on intravenous nutrition," Sokol said.

More information: "Phytosterols Promote Liver Injury and Kupffer Cell Activation in Parenteral Nutrition–Associated Liver Disease," by K.C. El Kasmi et al. Science Translational Medicine, 2013.

Related Stories

New treatment offers hope for short-bowel syndrome patients

Jul 18, 2013

A new drug, teduglutide, offers significant relief for patients with short-bowel syndrome intestinal failure who are reliant on intravenous nutrition, according to a new study in Clinical Gastroenterology and Hepatology, the of ...

Recommended for you

Overwhelmed west Africa ramps up Ebola response

4 hours ago

West Africa intensified its response to the deadly Ebola epidemic on Sunday, with Sierra Leone uncovering scores of dead bodies during a 72-hour shutdown and Liberia announcing hundreds of new hospital beds.

Sierra Leone reaches final day of Ebola lockdown

7 hours ago

Frustrated residents complained of food shortages in some neighborhoods of Sierra Leone's capital on Sunday as the country reached the third and final day of a sweeping, unprecedented lockdown designed to ...

Sierra Leone faces criticism over Ebola shutdown

Sep 20, 2014

Sierra Leone began the second day of a 72-hour nationwide shutdown aimed at containing the spread of the deadly Ebola virus on Saturday amid criticism that the action was a poorly planned publicity stunt.

Presence of peers ups health workers' hand hygiene

Sep 19, 2014

(HealthDay)—The presence of other health care workers improves hand hygiene adherence, according to a study published in the October issue of Infection Control and Hospital Epidemiology.

User comments